From his low-security prison in Pennsylvania, former pharmaceutical executive and so-called "Pharma Bro" Martin Shkreli this week continued to seek a reduction in his sentence, arguing that his confinement prevents him from mounting an effective defense in a "fast-paced and complex" civil suit brought by the Federal Trade Commission.